GET DAILY SIGNALSFutureFuel Corp. (FF) Slides -46% in 30 Days: Earnings Pressure and What Comes Next
Key Takeaways
- FutureFuel Corp. (FF) shares have fallen roughly 46% over the last 30 days, sliding from about $5.21 on October 13 to near $2.80.
- The decline was driven primarily by a steep post-earnings selloff after third-quarter 2026 results showed a GAAP net loss despite a sharp jump in revenue.
- A single-session drop of about 38% on unusually heavy volume followed the report, as elevated feedstock costs, derivatives losses, and chemical-segment maintenance outweighed stronger biofuel volumes.
- Over the last quarter, the stock is down more than 50%, retracing the gains recorded after stronger second-quarter results in early August.
- Management reported that more than 90% of fourth-quarter biodiesel capacity is already booked and pointed to upcoming regulatory changes as a potential margin tailwind, though near-term profitability remains under pressure.
- The board's reduced $0.01 quarterly dividend and a reaffirmed $25 million buyback program highlight a shift in capital allocation toward growth and share repurchases.
FutureFuel Corp. (FF) at a Glance
FutureFuel Corp. operates in two main areas: custom and performance chemicals, plus biofuels. The chemicals side focuses on specialty products for coatings, cleaning, oil and gas, and polymers, while the biofuels segment produces biodiesel and related blends. Its Arkansas facility supports steady customer ties, and management has noted growing interest in U.S.-based production. I follow the name for its ties to renewable fuel rules, plant utilization rates, and its track record of returning cash through dividends and repurchases.
Recent Price Action in Context
Over the past 30 days, FF has dropped approximately 46%, moving from a close of $5.21 on October 13, 2026, down to roughly $2.80 in mid-November. The bulk of that move came in one session after the third-quarter report, when the stock fell about 38% from $5.07 to $3.12 on elevated volume. Looking back over the full quarter, the shares are off more than 50% from the $5.85 level seen in mid-August, essentially giving back the earlier rally that followed second-quarter results.
Drivers Behind the Latest Move
The main trigger was the third-quarter 2026 earnings release on November 9. Revenue climbed sharply, up about 361% year over year to roughly $104.7 million, helped by better biofuel pricing and volume. Still, the company posted a GAAP loss of $0.19 per share, and the market reacted quickly the next day. In biofuels, higher volumes were offset by rising feedstock costs and derivative losses. On the chemicals side, maintenance work at key customer units cut sales volume by 27% and trimmed adjusted EBITDA by around $4.3 million. Those pressures outweighed the revenue gain and led to the sharp repricing.
Broader Quarterly Trends
The quarter has reflected a cooling in investor expectations. Shares had moved higher after second-quarter results showed a return to profitability and better utilization. Since then, attention has shifted to thinner margins, the cut in the quarterly dividend to $0.01, and ongoing questions around biofuel economics. The November reaction pulled those issues into focus. Management highlighted strong fourth-quarter bookings and a January 2027 regulatory shift that could help biodiesel relative to renewable diesel, yet near-term results are still expected to be loss-making.
Key Items to Monitor Going Forward
Several elements will likely influence the outlook. I’m watching whether fourth-quarter results convert the high biodiesel booking levels into better margins, and whether the planned sale of about 1.5 million RINs plus any derivative recovery can support profitability. The January 1, 2027, regulatory change for renewable fuels stands out as a potential positive for biodiesel’s competitive position. On the chemicals side, the return of normal ordering from major customers and the end of maintenance work are important markers. Management has also referenced a $41 million customer-funded investment at the Batesville site through 2028. Risks include feedstock volatility, derivative exposure, and margin pressure in both segments. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Exploring AI-Driven Trading Strategies
When I want to review systematic approaches alongside my own analysis, I often look at Tickeron’s Trending AI Robots page. It highlights a selection of top-performing automated strategies from a larger platform covering thousands of tickers. The bots differ in style, holding periods, and metrics, offering a useful way to compare options without sifting through everything manually.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Aroon Indicator for FF shows an upward move is likely
FF's Aroon Indicator triggered a bullish signal on November 06, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 193 similar instances where the Aroon Indicator showed a similar pattern. In 147 of the 193 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where FF advanced for three days, in 193 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
FF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FF as a result. In 58 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.
The Moving Average Convergence Divergence Histogram (MACD) for FF turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 29 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
FF moved below its 50-day moving average on November 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for FF crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 44%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.524) is normal, around the industry mean (2.284). P/E Ratio (-8.867) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (1.548). Dividend Yield (0.008) settles around the average of (0.039) among similar stocks. P/S Ratio (1.553) is also within normal values, averaging (48.960).
The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. FF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of specialty chemicals and biofuels
Industry ChemicalsSpecialty
Advertisement